Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial.
Kuwabara S, Shibuya K, Tomizawa Y, Ogata H, Shima S, Kuga A, Suzuki C, Kudou K, Li Z, Hakan A, et al.
